Korean J Physiol Pharmacol.  1997 Dec;1(6):691-697.

The c-myc expression on the opioid tolerance in human neuroblastoma SH-SY5Y cells

  • 1Department of Pharmacology, Keimyung University, School of Medicine, Taegu 700-712, South Korea.
  • 2Department of Microbiology, Keimyung University, School of Medicine, Taegu 700-712, South Korea.
  • 3Department of Institute for Medical Science, Keimyung University, School of Medicine, Taegu 700-712, South Korea.


The mechanisms underlying opiate tolerance and dependence are not fully understood. We used human neuroblastoma SH-SY5Y cells as a model system for studying effects of morphine tolerance and withdrawal on c-myc induction and cAMP levels. It has been reported that regulation of c-fos by acute and chronic morphine withdrawal is mediated through alterations in CREB transcription factor. In this study, we examined the effects of morphine tolerance on c-myc expression and cAMP concentrations. The activation of opiate receptors by an acute morphine administration resulted in an increase in c-myc mRNA and a decrease in cAMP concentrations in a dose-dependent manner (5, 10, 15, and 20 muM). On the other hand, the chronic treatment of morphine (10 muM for six days) did not induce the elevated expression of c-myc mRNA. The c-myc expression was slightly inhibited in comparison with that of the acute morphine response. However, cAMP concentrations were increased with regard to morphine withdrawal response. These results suggest that the alterations in c-myc expression might imply a significant opiate regulation relating to morphine tolerance. This observation differs from increased expression of c-fos via regulation of cAMP pathway.


Human neuroblastoma SH-SY5Y cells; c-myc; cAMP

MeSH Terms

Receptors, Opioid
RNA, Messenger
Transcription Factors
RNA, Messenger
Receptors, Opioid
Transcription Factors
Full Text Links
  • KJPP
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr